Clinical practice guideline (update): Adult sinusitis

Otolaryngology - Head and Neck Surgery (United States)

Volumn 152, Issue , 2015, Pages S1-S39

  Rosenfeld, Richard M ^a   Piccirillo, Jay F ^b   Chandrasekhar, Sujana S ^c   Brook, Itzhak ^d   Ashok Kumar, Kaparaboyna ^e   Kramper, Maggie ^f   Orlandi, Richard R ^g   Palmer, James N ^h   Patel, Zara M ⁱ   Peters, Anju ^j   Walsh, Sandra A ^k   Corrigan, Maureen D ^l  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c New York Head & Neck Institute   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

^k Consumers United for Evidence Based Healthcare ^*  (United States)

^l AAO HNS   (United States)

more..

Author keywords

adult sinusitis; rhinosinusitis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; GUAIFENESIN; PENICILLIN DERIVATIVE; PLACEBO; SODIUM CHLORIDE; STEROID; ANTIINFECTIVE AGENT;

ACUTE BACTERIAL RHINOSINUSITIS; ACUTE RHINOSINUSITIS; ADULT DISEASE; ALLERGY TEST; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; ASTHMA; BACTERIAL SINUSITIS; BACTERIOLOGY; CHRONIC RHINOSINUSITIS; CILIARY DYSKINESIA; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG TREATMENT FAILURE; ENDOSCOPY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; MEDICAL DOCUMENTATION; META ANALYSIS (TOPIC); NASAL ENDOSCOPY; NASAL LAVAGE; NOSE POLYP; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINOSINUSITIS; SINONASAL INFLAMMATION; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC THERAPY; TOPICAL TREATMENT; TOTAL QUALITY MANAGEMENT; TREATMENT DURATION; VIRAL RHINOSINUSITIS; VIRAL UPPER RESPIRATORY TRACT INFECTION; WATCHFUL WAITING; ADULT; MEDICAL SOCIETY; ORGANIZATION; OTORHINOLARYNGOLOGY; PROCEDURES; RHINITIS; SINUSITIS; UNITED STATES;

ACADEMIES AND INSTITUTES; ADULT; ANTI-BACTERIAL AGENTS; HUMANS; OTOLARYNGOLOGY; RHINITIS; SINUSITIS; SOCIETIES, MEDICAL; UNITED STATES; WATCHFUL WAITING;

EID: 84926325117     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599815572097     Document Type: Article

References (177)

1. Rosenfeld R.M, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007 ; 137 (3). S1 - S31
2. Clinical Practice Guidelines We Can Trust. Washington, D.C: National Academies Press ; 2011:
3. Lethbridge-Cejku M, Rose D, Vickerie J. Summary health statistics for U.S adults: National Health Interview Survey, 2004. Vital Health Stat. 2006 ; 10: 19-22
4. Blackwell D.L, Lucas J.W, Clarke T.C. Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat. 2014 ; 10: 1-171
5. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2004 ; 130: 1-45
6. Rudmik L, Smith T.L, Schlosser R.J, et al. Productivity costs in patients with refractory chronic rhinosinusitis. Laryngoscope. 2014 ; 124: 2007-2012
7. Stankiewicz J, Tami T, Truitt T, et al. Impact of chronic rhinosinusitis on work productivity through one-year follow-up after balloon dilation of the ethmoid infundibulum. Int Forum Allergy Rhinol. 2011 ; 1: 38-45
8. Gliklich R.E, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995 ; 113: 104-109
9. Kaszuba S.M, Stewart M.G. Medical management and diagnosis of chronic rhinosinusitis: a survey of treatment patterns by United States otolaryngologists. Am J Rhinol. 2006 ; 20: 186-190
10. Winstead W. Rhinosinusitis. Primary Care. 2003 ; 30: 137-154
11. Snow V, Mottur-Pilson C, Hickner J.M, et al. Principles of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med. 2001 ; 134: 495-497
12. Bhattacharyya N. Chronic rhinosinusitis: is the nose really involved?. Am J Rhinol. 2001 ; 15: 169-173
13. Meltzer E.O, Hamilos D.L, Hadley J.A, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg. 2004 ; 131 (6). S1 - S62
14. Scadding G.K, Durham S.R, Mirakian R. B.S.A.C.I guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy. 2007 ; 38: 260-275
15. Chow A.W, Benninger M.S, Brook I, et al. I.D.S.A clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012 ; 54: e72 - e112
16. Desrosiers M, Evans G.A, Keith P.K, et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol. 2011 ; 7: 2
17. Clayman G.L, Adams G.L, Paugh D.R, et al. Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope. 1991 ; 101: 234-239
18. Hytönen M, Atula T, Pitkäranta A. Complications of acute sinusitis in children. Acta Otolaryngol. 2000 ; 543: 154-157
19. Fokkens W.J, Lund V.J, Mullol J. European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl. 2012 ; 50: 1-298
20. Smith S.S, Evans C.T, Tan B.K, et al. National burden of antibiotic use for adult rhinosinusitis. J Allergy Clin Immun. 2013 ; 132: 1230-1232
21. Wu J.H, Howard D.H, McGowan J.E, et al. Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia. Clin Ther. 2004 ; 26: 2153-2162
22. Bhattacharyya N, Grebner J, Martinson N.G. Recurrent acute rhinosinusitis: epidemiology and health care cost burden. Otolaryngol Head Neck Surg. 2012 ; 146: 307-312
23. Anand V.K. Epidemiology and economic impact of rhinosinusitis. Ann Oto Rhinol Laryngol. 2004 ; 193: 3-5
24. Ray N.F, Baraniuk J.N, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immun. 1999 ; 103: 408-414
25. Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Oto Rhinol Laryngol. 2011 ; 120: 423-427
26. Bhattacharyya N, Orlandi R.R, Grebner J, et al. Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol Head Neck Surg. 2011 ; 144: 440-445
27. Bhattacharyya N. Assessing the additional disease burden of polyps in chronic rhinosinusitis. Ann Otol Rhinol Laryngol. 2009 ; 118: 185-189
28. Soler Z.M, Wittenberg E, Schlosser R.J, et al. Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope. 2011 ; 121: 2672-2678
29. Chester A.C, Sindwani R, Smith T.L, et al. Systematic review of change in bodily pain after sinus surgery. Otolaryngol Head Neck Surg. 2008 ; 139: 759-765
30. Chester A.C, Sindwani R, Smith T.L, et al. Fatigue improvement following endoscopic sinus surgery: a systematic review and meta-analysis. Laryngoscope. 2008 ; 118: 730-739
31. Rudmik L, Mace J, Soler Z.M, et al. Long-term utility outcomes in patients undergoing endoscopic sinus surgery. Laryngoscope. 2014 ; 124: 19-23
32. Rosenfeld R.M, Shiffman R.N, Robertson P, et al. Clinical Practice Guideline Development Manual, Third Edition: a quality-driven approach for translating evidence into action. Otolaryngol Head Neck Surg. 2013 ; 148 (1). S1 - S55
33. Setzen G, Ferguson B.J, Han J.K, et al. Clinical consensus statement: appropriate use of computed tomography for paranasal sinus disease. Otolaryngol Head Neck Surg. 2012 ; 147: 808-816
34. Shiffman R.N, Dixon J, Brandt C, et al. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. B.M.C Med Inform Decis. 2005 ; 5: 23
35. Classifying recommendations for clinical practice guidelines. Pediatrics. 2004 ; 114: 874-877
36. Eddy D.M. Clinical decision making: from theory to practice: cost-effectiveness analysis. Will it be accepted?. J.A.M.A. 1992 ; 268: 132-136
37. Choudhry N.K, Stelfox H.T, Detsky A.S. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. J.A.M.A. 2002 ; 287: 612-617
38. Detsky A.S. Sources of bias for authors of clinical practice guidelines. Can Med Assoc J. 2006 1035 ; 175 1033:
39. Colla C.H, Morden N.E, Sequist T.D, Schpero W.L, Rosenthal M.B. Choosing wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med. 2014 ;:
40. Albrich W.C, Monnet D.L, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis. 2004 ; 10: 514-517
41. Bronzwaer S.L, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002 ; 8: 278-282
42. Seppala H, Klaukka T, Lehtonen R, et al. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis. 1995 ; 21: 1378-1385
43. Steinke D, Davey P. Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clin Infect Dis. 2001 ; 33: S193 - S205
44. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005 ; 365: 579-587
45. Schreiber C.P, Hutchinson S, Webster C.J, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache. Arch Intern Med. 2004 ; 164: 1769-1772
46. Kari E, DelGaudio J.M. Treatment of sinus headache as migraine: the diagnostic utility of triptans. Laryngoscope. 2008 ; 118: 2235-2239
47. Slavin R.G, Spector S.L, Bernstein I.L, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immun. 2005 ; 116 (6). S13 - S47
48. Ip S, Fu L, Balk E, et al Update on Acute Bacterial Rhinosinusitis. Rockville, M.D: Agency for Healthcare Research and Quality ; 2005:
49. LaCroix J.S, Ricchetti A, Lew D. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. Acta Otolaryngol. 2002 ; 122: 192-196
50. Van Den Broek M.F, Gudden C, Kluijfhout W.P, et al. No evidence for distinguishing bacterial from viral acute rhinosinusitis using symptom duration and purulent rhinorrhea: a systematic review of the evidence base. Otolaryngol Head Neck Surg. 2014 ; 150: 533-537
51. Axelsson A, Runze U. Symptoms and signs of acute maxillary sinusitis. O.R.L J Otorhinolaryngol Rel Spec. 1976 ; 38: 298-308
52. Axelsson A, Runze U. Comparison of subjective and radiological findings during the course of acute maxillary sinusitis. Ann Oto Rhinol Laryngol. 1983 ; 92: 75-77
53. Williams J, Simel D.L, Roberts L, et al. Clinical evaluation for sinusitis: making the diagnosis by history and physical examination. Ann Intern Med. 1992 ; 117: 705-710
54. Berg O, Carenfelt C, Rystedt G, et al. Occurrence of asymptomatic sinusitis in common cold and other acute E.N.T.-infections. Rhinology. 1986 ; 24: 223-225
55. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol. 1988 ; 105: 343-349
56. Lindbaek M, Hjortdahl P, Johnsen U.L. Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care: comparison with computed tomography. Fam Med. 1996 ; 28: 183-188
57. Lindbaek M, Hjortdahl P. The clinical diagnosis of acute purulent sinusitis in general practice - a review. Br J Gen Pract. 2002 ; 52: 491-495
58. Mudgil S.P, Wise S.W, Hopper K.D, et al. Correlation between presumed sinusitis-induced pain and paranasal sinus computed tomographic findings. Ann Allerg Asthma Im. 2002 ; 88: 223-226
59. Fokkens W.J, Lund V.J, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps. Rhinology Suppl. 2012 ; 23: 1-298
60. Lanza D.C, Kennedy D.W. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 1997 ; 117: S1 - S7
61. Fokkens W, Lund V, Bachert C, et al. E.A.A.C.I position paper on rhinosinusitis and nasal polyps executive summary. Allergy. 2005 ; 60: 583-601
62. Benninger M.S, Appelbaum P.C, Denneny J.C, et al. Maxillary sinus puncture and culture in the diagnosis of acute rhinosinusitis: the case for pursuing alternative culture methods. Otolaryngol Head Neck Surg. 2002 ; 127: 7-12
63. Benninger M.S, Payne S.C, Ferguson B.J, et al. Endoscopically directed middle meatal cultures versus maxillary sinus taps in acute bacterial maxillary rhinosinusitis: a meta-analysis. Otolaryngol Head Neck Surg. 2006 ; 134: 3-9
64. Gwaltney M.J. Acute community acquired sinusitis. Clin Infect Dis. 1996 ; 23: 1209-1223
65. Stringer S.P, Mancuso A.A, Avino A.J. Effect of a topical vasoconstrictor on computed tomography of paranasal sinus disease. Laryngoscope. 1993 ; 103: 6-9
66. Gwaltney M.J, Scheld W.M, Sande M.A, et al. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. Clin Immunol. 1992 ; 90: 457-462
67. Gwaltney M.J, Hendley J.O, Simon G. Rhinovirus infection in an industrial population, I.I: characteristics of illness and antibody response. J.A.M.A. 1967 ; 202: 494-500
68. Hauer A.J, Luiten E.L, van Erp N.F, et al. No evidence for distinguishing bacterial from viral acute rhinosinusitis using fever and facial/dental pain: a systematic review of the evidence base. Otolaryngol Head Neck Surg. 2014 ; 150: 28-33
69. Wald E.R, Applegate K.E, Bordley C, et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013 ; 132: e262 - e280
70. Cornelius R.S, Martin J, Wippold F.J, et al. A.C.R appropriateness criteria sinonasal disease. J.A.C.R. 2013 ; 10: 241-246
71. Balk E.M, Zucker D.R, Engels E.A, et al. Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis. J Gen Intern Med. 2001 ; 16: 701-711
72. Hickner J.M, Bartlett J.G, Besser R.E, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med. 2001 ; 134: 498-505
73. Lau J, Zucker D, Engels E.A, et al Diagnosis and Treatment of Acute Bacterial Rhinosinusitis. Rockville, M.D: Agency for Healthcare Research and Quality ; 1999:
74. Gwaltnery J.M, Phillips C.D, Miller R.D, Riker D.K. Computed tomographic study of the common cold. N Engl J Med. 1994 ; 330: 25-30
75. Younis R.T, Anand V.K, Davidson B. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope. 2002 ; 112: 224-229
76. Mafee M.F, Tran B.H, Chapa A.R. Imaging of rhinosinusitis and its complications: plain film, C.T, and M.R.I. Clin Rev Allergy Immunol. 2006 ; 30: 165-186
77. Hoxworth J.M, Glastonbury C.M. Orbital and intracranial complications of acute sinusitis. Neuroimag Clin North Am. 2010 ; 20: 511-526
78. Bhattacharyya T, Piccirillo J, Wippold F.J. Relationship between patient-based descriptions of sinusitis and paranasal sinus computed tomographic findings. Arch Otolaryngol. 1997 ; 123: 1189-1192
79. Havas T.E, Motbey J.A, Gullane P.J. Prevalence of incidental abnormalities on computed tomographic scans of the paranasal sinuses. Arch Otolaryngol. 1988 ; 114: 856-859
80. Bolger W.E, Butzin C.A, Parsons D.S. Paranasal sinus bony anatomic variations and mucosal abnormalities: C.T analysis for endoscopic sinus surgery. Laryngoscope. 1991 ; 101: 56-64
81. Hays G.C, Mullard J.E. Can nasal bacterial flora be predicted from clinical findings?. Pediatrics. 1972 ; 49: 596-599
82. Winther B. Effects on the nasal mucosa of upper respiratory viruses (common cold). Dan Med Bull. 1994 ; 41: 193-204
83. Winther B, Brofeldt S, Grønborg H, et al. Study of bacteria in the nasal cavity and nasopharynx during naturally acquired common colds. Acta Otolaryngol. 1984 ; 98: 315-320
84. Lund V.J. Therapeutic targets in rhinosinusitis: infection or inflammation?. Medscape J Med. 2008 ; 10: 105
85. Aroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2005 ; (3). C.D000247 1
86. Kassel J.C, King D, Spurling G.K. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2010 ; (3). C.D006821
87. Mortuaire G, de Gabory L, François M, et al. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel. Eur Ann Otorhinolaryngol Head Neck Dis. 2013 ; 130: 137-144
88. Hayward G, Heneghan C, Perera R, et al. Intranasal corticosteroids in management of acute sinusitis: a systematic review and meta-analysis. Ann Fam Med. 2012 ; 10: 241-249
89. Barlan I.B, Erkan E, Bakir M, et al. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol. 1997 ; 78: 598-601
90. Meltzer E.O, Charous B.L, Busse W.W, et al. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol. 2000 ; 106: 630-637
91. Meltzer E.O, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005 ; 116: 1289-1295
92. Dolor R.J, Witsell D.L, Hellkamp A.S, et al. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The C.A.F.F.S Trial: a randomized controlled trial. J.A.M.A. 2001 ; 286: 3097-3105
93. Meltzer E.O, Orgel H.A, Backhaus J.W, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. Clin Immunol. 2003 ; 92: 812-823
94. Williamson I.G, Rumsby K, Benge S, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. J.A.M.A. 2007 ; 298: 2487-2496
95. Zalmanovici A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013 ; 2: C.D005149
96. Venekamp R.P, Thompson M.J, Hayward G, et al. Systemic corticosteroids for acute sinusitis. Cochrane Database Syst Rev. 2014 ; 3: C.D008115
97. Inanli S, Oztürk O, Korkmaz M, et al. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo. Laryngoscope. 2002 ; 112: 320-325
98. Rabago D, Zgierska A, Mundt M, et al. Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. J Fam Pract. 2002 ; 51: 1049-1055
99. Keojampa B.K, Nguyen M.H, Ryan M.W. Effects of buffered saline solution on nasal mucociliary clearance and nasal airway patency. Otolaryngol Head Neck Surg. 2004 ; 131: 679-682
100. Talbott G.A, Lynn A.M, Levy F.H, et al. Respiratory arrest precipitated by codeine in a child with chronic renal failure. Clin Pediatr. 1997 ; 36: 171-173
101. Wabnitz D.A.M, Wormald P.-J. A blinded, randomized, controlled study on the effect of buffered 0.9% and 3% sodium chloride intranasal sprays on ciliary beat frequency. Laryngoscope. 2005 ; 115: 803-805
102. Adam P, Stiffman M, Blake R.L. A clinical trial of hypertonic saline nasal spray in subjects with the common cold or rhinosinusitis. Arch Fam Med. 1998 ; 7: 39-43
103. Eccles R, Jawad M.S.M, Jawad S.S.M, et al. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am J Rhinol. 2005 ; 19: 25-31
104. Jawad S.S, Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology. 1998 ; 36: 73-76
105. Latte J, Taverner D, Slobodian P, et al. A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza. Clin Exp Pharmacol. 2004 ; 31: 429-432
106. Sperber S.J, Turner R.B, Sorrentino J.V, et al. Effectiveness of pseudoephedrine plus acetaminophen for treatment of symptoms attributed to the paranasal sinuses associated with the common cold. Arch Fam Med. 2000 ; 9: 979-985
107. Taverner D, Danz C, Economos D. The effects of oral pseudoephedrine on nasal patency in the common cold: a double-blind single-dose placebo-controlled trial. Clin Otolaryngol. 1999 ; 24: 47-51
108. Caenan M, Hamels K, Deron P, et al. Comparison of decongestive capacity of xylometazoline and pseudoephedrine with rhinomanometry and M.R.I. Rhinology. 2005 ; 43: 205-209
109. Zeiger R.S. Prospects for ancillary treatment of sinusitis in the 1990s. J Allergy Clin Immunol. 1992 ; 90: 478-495
110. Braun J.J, Alabert J.P, Michel F.B, et al. Adjunct effect of loratadine in the treatment of acute sinusitis in patients with allergic rhinitis. Allergy. 1997 ; 52: 650-655
111. Welch M.J, Meltzer E.O, Simons F.E.R. H1-antihistamines and the central nervous system. Clin Allergy Immunol. 2002 ; 17: 337-388
112. Ahovuo-Saoranta A, Rautakorpi U.M, Borisenko O.V, et al. Antibiotics for acute maxillary sinusitis in adults. Cochrane Database Syst Rev. 2014 ; 11: C.D000243
113. Lemiengre M.B, van Driel M.L, Merenstein D, et al. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev. 2012 ; 10: C.D006089
114. Young J, De Sutter A, Merenstein D, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet. 2008 ; 371: 908-914
115. Falagas M.E, Giannopoulou K.P, Vardakas K.Z, et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. Lancet. 2008 ; 8: 543-552
116. Broeder T.P, Grooteman K.V, Overdijkink S.B, et al. Inconclusive evidence that age predicts a prolonged or chronic course of acute rhinosinusitis in adults: a systematic review of the evidence base. Otolaryngol Head Neck Surg. 2014 ; 150: 365-370
117. Frerichs K.A, Nigten G, Romeijn K. Inconclusive evidence for allergic rhinitis to predict a prolonged or chronic course of acute rhinosinusitis. Otolaryngol Head Neck Surg. 2014 ; 150: 22-27
118. Henry D.C, Riffer E, Sokol W.N, et al. Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. Antimicrob Agents Chemother. 2003 ; 47: 2770-2774
119. Luterman M, Tellier G, Lasko B, et al. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis. Ear Nose Throat J. 2003 ; 82: 576 582-580
120. de Bock G.H, Dekker F.W, Stolk J, et al. Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol. 1997 ; 50: 881-890
121. Lau J, Zucker D, Engels E.A, et al Diagnosis and Treatment of Acute Bacterial Rhinosinusitis. Rockville, M.D: Agency for Healthcare Research and Quality ; 1999:
122. Low D.E, Desrosiers M, McSherry J. A practical guide for the diagnosis and treatment of acute sinusitis. C.M.A.J. 1997 ; 156: 1-14
123. Brook I, Foote P.A, Hausfeld J.N. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. J Med Microbiol. 2006 ; 55: 943-946
124. Jenkins S.G, Farrell D.J, Patel M, et al. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the U.S.A, 2000-2003: P.R.O.T.E.K.T U.S years 1-3. J Infect. 2005 ; 51: 355-363
125. Brook I, Gober A.E. Resistance to antimicrobials used for therapy of otitis media and sinusitis: effect of previous antimicrobial therapy and smoking. Ann Otol Rhinol Laryngol. 1999 ; 108: 645-647
126. Karageorgopoulos D.E, Giannopoulou K.P, Grammatikos A.P, et al. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. C.M.A.J. 2008 ; 178: 845-854
127. Harrison C.J, Woods C, Stout G, et al. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009 ; 63: 511-519
128. Falagas M.E, Karageorgopoulos D.E, Grammatikos A.P, et al. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol. 2009 ; 67: 161-171
129. Contopoulos-Ioannidis D.G, Ioannidis J.P, Chew P, et al. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. J Antimicrob Chemother. 2001 ; 48: 691-703
130. Roos K, Tellier G, Baz M, et al. Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis. J Infect. 2005 ; 50: 210-220
131. Ah-see K. Sinusitis (acute). Clin Evidence. 2006 ; 15: 1-11
132. Slavin R.G. Sinusitis: viral, bacterial, or fungal and what is the role of Staph?. Allergy Asthma Proc. 2006 ; 27: 447-450
133. Gwaltney J.M, Sydnor A, Sande M.A. Etiology and antimicrobial treatment of acute sinusitis. Ann Otol Rhinol Laryngol. 1981 ; 90: 68-71
134. Berg O, Carenfelt C, Kronvall G. Bacteriology of maxillary sinusitis in relation to character of inflammation and prior treatment. Scand J Infect Dis. 1988 ; 20: 511-516
135. Brook I. Microbiology and management of sinusitis. J Otolaryngol. 1996 ; 25: 249-256
136. Payne S.C, Benninger M.S. Staphylococcus aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis. Clin Infect Dis. 2007 ; 45: e121 - e127
137. Bonilla F.A, Bernstein I.L, Khan D.A, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005 ; 94 (5). S1 - S63
138. Lange B, Holst R, Thilsing T, et al. Quality of life and associated factors in persons with chronic rhinosinusitis in the general population. Clin Otolaryngol. 2013 ; 38 (6). 474-480
139. Samter M, Beers R.F. Concerning the nature of intolerance to aspirin. J Allergy. 1967 ; 40: 281-293
140. Settipane G.A, Chafee F.H. Nasal polyps in asthma and rhinitis: a review of 6,037 patients. J Allergy Clin Immunol. 1977 ; 59: 17-21
141. Drake-Lee A.B, Lowe D, Swanston A, et al. Clinical profile and recurrence of nasal polyps. J Laryngol Otol. 1984 ; 98: 783-793
142. Caplin I, Haynes J.T, Spahn J. Are nasal polyps an allergic phenomenon?. Ann Allergy. 1971 ; 29: 631-634
143. Settipane G.A. Epidemiology of nasal polyps. Allergy Asthma Proc. 1996 ; 17: 231-236
144. Bhattacharyya N, Lee L.N. Evaluating the diagnosis of chronic rhinosinusitis based on clinical guidelines and endoscopy. Otolayrngol Head Neck Surg. 2010 ; 143: 147-151
145. Meltzer E.O, Hamilos D.L. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc. 2011 ; 86: 427-443
146. Soler Z.M, Oyer S.L, Kern R.C, et al. Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations. Int Forum Allergy Rhinol. 2013 ; 3: 31-47
147. Joe S.A, Thambi R, Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2008 ; 139: 340-347
148. Kalish L, Snidvongs K, Sivasubramaniam R, et al. Topical steroids for nasal polyps. Cochrane Database Syst Rev. 2012 ; 12: C.D006549
149. Wei C.C, Adappa N.D, Cohen N.A. Use of topical nasal therapies in the management of chronic rhinosinusitis. Laryngoscope. 2013 ; 123: 2347-2359
150. Hissaria P, Smith W, Wormald P.J, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006 ; 118: 128-133
151. Benitez P, Alobid H, Berenguer M, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope. 2006 ; 116: 770-775
152. Poetker D.M, Jakubowski L.A, Lal D. Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2012 ; 3: 104-120
153. Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol. 1995 ; 20: 26-30
154. Aukema A.A.C, Mulder P.G.H, Fokkens W.J. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol. 2005 ; 115: 1017-1023
155. Harvey R, Hannan S.A, Badia L, et al. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007 ; 3: C.D006394
156. van den Berg J.W, de Nier L.M, Kaper N.M, et al. Limited evidence: higher efficacy of nasal saline irrigation over nasal saline spray in chronic rhinosinusitis - an update and reanalysis of the evidence base. Otolaryngol Head Neck Surg. 2014 ; 150: 16-21
157. Pynnonen M.A, Mukerji S.S, Kim H.M, et al. Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg. 2007 ; 133: 1115-1120
158. Tomooka L.T, Murphy C, Davidson T.M. Clinical study and literature review of nasal irrigation. Laryngoscope. 2000 ; 110: 1189-1193
159. Fokkens W, Lund V, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology Suppl. 2007 ; (20). 1-136
160. Mullol J, Obando A, Pujols L, et al. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin North Am. 2009 ; 29: 657-668
161. Snidvongs K, Kalish L, Sacks R, et al. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev. 2011 ; (8). C.D009274
162. Rudmik L, Hoy M, Schlosser R.J, et al. Topical therapies in the management of chronic rhinosinusitis: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2013 ; 3: 281-298
163. Scadding G.K, Durham S.R, Mirakian R, et al. B.S.A.C.I guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy. 2008 ; 38: 260-275
164. LaForce C, Journeay G.E, Miller S.D, et al. Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study. Ann Allergy Asthma Immunol. 2013 ; 111: 45-50
165. Giger R, Pasche P, Cheseaux C, et al. Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueos nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis. Eur Arch Otorhinolaryngol. 2003 ; 260: 135-140
166. Sacks P.-L, Harvey R.J, Rimmer J, et al. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev. 2011 ; 8: C.D008263
167. Isaacs A, Fakhri S, Luong A, et al. meta-analysis of topical amphotericin B for the treatment of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2011 ; 4: 250-254
168. Ponikau J.U, Sherris D.A, Kephart G.M, et al. Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis. J Allergy Clin Immun. 2005 ; 116: 362-369
169. Ponikau J.U, Sherris D.A, Kern E.B, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999 ; 74: 877-884
170. Taylor M.J, Ponikau J.U, Sherris D.A, et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg. 2002 ; 127: 377-383
171. Kim S.T, Choi J.H, Jeon H.G, et al. Comparison between polymerase chain reaction and fungal culture for the detection of fungi in patients with chronic sinusitis and normal controls. Acta Otolaryngol. 2005 ; 125: 72-75
172. Shin S.-H, Ponikau J.U, Sherris D.A, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Im. 2004 ; 114: 1369-1375
173. Ponikau J.U, Sherris D.A, Kephart G.M, et al. The role of ubiquitous airborne fungi in chronic rhinosinusitis. Clin Rev Allergy Immunol. 2006 ; 30: 187-194
174. Thanasumpun T, Batra P.S. Oral antifungal therapy for chronic rhinosinusitis and its subtypes: a systematic review. Int Forum Allergy Rhinol. 2011 ; 1: 382-389
175. Gosepath J, Grebneva N, Mossikhin S, et al. Topical antibiotic, antifungal, and antiseptic solutions decrease ciliary activity in nasal respiratory cells. Am J Rhinol. 2002 ; 16: 25-31
176. Shirazi M.A, Stankiewicz J.A, Kammeyer P. Activity of nasal amphotericin B irrigation against fungal organisms in vitro. Am J Rhinol. 2007 ; 21: 145-148
177. Centers for Disease Control and Prevention. Get smart: know when antibiotics work. http://wwwcdcgov/drugresistance/community/campaign-materialshtm#3. Accessed March 23, 2007.